Key Points

In Week 22, there was a marked decrease in SARS-CoV-2 circulation across the entire country and a reduction in pressure on hospitals. All-cause mortality is once again within expected ranges.

• Decrease in incidence rates, hospitalizations, and critical care admissions

• All-cause mortality is once again within expected ranges at the national level

• Mainland France: Decrease in viral circulation across all regions

• Overseas territories: incidence rates remain high in French Guiana

• Variants:

  • Variant 20I/501Y.V1 (Alpha) remains the dominant variant in mainland France

  • Variant 21A/478K (B.1.617.2, Delta) very rarely detected as of May 25 (Flash Survey #10) but with a trend toward an increase in the number of cases and clusters linked to local transmission.

• More information on the circulation of variants

Prevention

• Vaccination: as of June 7

  • 28,310,571 people have received at least one dose, vaccination coverage of 42.2%

  • 14,017,162 people fully vaccinated, vaccination coverage of 20.9%

  • More information on COVID-19 vaccination

• Promotion of vaccination for everyone aged 18 and older

• Necessity of adhering to preventive measures and limiting contact

• If symptoms develop, immediate isolation is required, and a test should be taken as soon as possible

• Importance of contact tracing to limit the spread of the epidemic and SARS-CoV-2 variants

More information on the COVID-19 pandemic

• Coronavirus (COVID-19) Report

• Key figures and trends of COVID-19 in France and around the world

• Find all national epidemiological updates here